NE10790, a phosphonocarboxylate analogue of risedronate, induces human myeloma cell apoptosis in vitro

Ähnliche Einträge

• Risedronate, and its phosphonocarboxylate analogue NE10790, both induce apoptosis, but have differential effects on the cell cycle and protein prenylation in human myeloma cells.
  von: Roelofs, A, et al.
  Veröffentlicht: (2004)
• Selective inhibition of Rab prenylation by a phosphonocarboxylate analogue of risedronate induces apoptosis, but not S-phase arrest, in human myeloma cells.
  von: Roelofs, A, et al.
  Veröffentlicht: (2006)
• Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
  von: Marma, MS, et al.
  Veröffentlicht: (2007)
• Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
  von: Roelofs, A, et al.
  Veröffentlicht: (2005)
• Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.
  von: Kashemirov, B, et al.
  Veröffentlicht: (2008)